N-[1-(2-fluorophenyl)propan-2-yl]-4-[[4-(morpholin-4-ylmethyl)benzoyl]amino]thiophene-2-carboxamide
C26H28FN3O3S — CID 142786193
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-(2-fluorophenyl)propan-2-yl]-4-[[4-(morpholin-4-ylmethyl)benzoyl]amino]thiophene-2-carboxamide
N-[1-(2-fluorophenyl)propan-2-yl]-4-[[4-(morpholin-4-ylmethyl)benzoyl]amino]thiophene-2-carboxamide (PubChem CID 142786193) has the molecular formula C26H28FN3O3S and a molecular weight of 481.59 g/mol. Its IUPAC name is N-[1-(2-fluorophenyl)propan-2-yl]-4-[[4-(morpholin-4-ylmethyl)benzoyl]amino]thiophene-2-carboxamide.
Molecular Properties
| Compound Name | N-[1-(2-fluorophenyl)propan-2-yl]-4-[[4-(morpholin-4-ylmethyl)benzoyl]amino]thiophene-2-carboxamide |
|---|---|
| PubChem CID | 142786193 |
| Molecular Formula | C26H28FN3O3S |
| Molecular Weight | 481.59 g/mol |
| Exact Mass | 481.18 |
| IUPAC Name | N-[1-(2-fluorophenyl)propan-2-yl]-4-[[4-(morpholin-4-ylmethyl)benzoyl]amino]thiophene-2-carboxamide |
| SMILES | CC(Cc1ccccc1F)NC(=O)c1cc(NC(=O)c2ccc(CN3CCOCC3)cc2)cs1 |
| InChI | InChI=1S/C26H28FN3O3S/c1-18(14-21-4-2-3-5-23(21)27)28-26(32)24-15-22(17-34-24)29-25(31)20-8-6-19(7-9-20)16-30-10-12-33-13-11-30/h2-9,15,17-18H,10-14,16H2,1H3,(H,28,32)(H,29,31) |
| InChIKey | IPTWMYNBBGBBOE-UHFFFAOYSA-N |
| XLogP | 4.33 |
| TPSA | 70.67 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 481.59 |
| LogP ≤ 5 | 4.33 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142786193 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.